GSK and Vir launch collaboration on coronavirus
In two separate announcements, GSK unveils that it will partner with Vir to combat COVID-19, as well as investing in the biotech.
Archives for April 7, 2020
Servier acquires Symphogen to pick up oncology pipeline
Servier buy outs its former partner to bolster its antibody discovery and development capabilities within oncology.
Gilead agrees microbiome deal with Second Genome
Gilead announces partnership to identify microbiome biomarkers associated with a clinical response in compounds within its portfolio.